Facility #1

Warsaw 01-684

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Hepatocellular Carcinoma (HCC)

Studies at this site

• A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma — Completed
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early